Azenta, Inc. (NASDAQ:AZTA – Get Free Report) has been assigned a consensus rating of “Hold” from the seven research firms that are covering the company, MarketBeat.com reports. One analyst has rated the stock with a sell rating, two have issued a hold rating and four have assigned a buy rating to the company. The average twelve-month price target among brokers that have issued ratings on the stock in the last year is $41.20.
A number of analysts have recently commented on the company. Weiss Ratings upgraded Azenta from a “sell (e+)” rating to a “sell (d-)” rating in a report on Wednesday, August 26th. Wall Street Zen upgraded Azenta from a “hold” rating to a “buy” rating in a report on Saturday. Finally, Needham & Company LLC reiterated a “buy” rating and issued a $37.00 target price on shares of Azenta in a report on Monday, September 14th.
View Our Latest Stock Report on Azenta
Azenta Stock Performance
Azenta (NASDAQ:AZTA – Get Free Report) last posted its quarterly earnings results on Tuesday, August 4th. The company reported $0.16 earnings per share for the quarter, topping analysts’ consensus estimates of $0.11 by $0.05. The company had revenue of $161.18 million for the quarter, compared to the consensus estimate of $149.31 million. Azenta had a negative net margin of 20.63% and a positive return on equity of 1.18%.
Hedge Funds Weigh In On Azenta
A number of large investors have recently modified their holdings of the company. Green Alpha Advisors LLC grew its holdings in shares of Azenta by 3.5% during the 3rd quarter. Green Alpha Advisors LLC now owns 9,187 shares of the company’s stock worth $321,000 after purchasing an additional 313 shares during the period. Rockefeller Capital Management L.P. increased its position in Azenta by 98.0% during the 4th quarter. Rockefeller Capital Management L.P. now owns 1,392 shares of the company’s stock worth $46,000 after purchasing an additional 689 shares in the last quarter. Kera Capital Partners Inc. increased its position in Azenta by 7.7% during the 4th quarter. Kera Capital Partners Inc. now owns 11,034 shares of the company’s stock worth $367,000 after purchasing an additional 787 shares in the last quarter. KBC Group NV raised its holdings in Azenta by 102.2% in the first quarter. KBC Group NV now owns 2,449 shares of the company’s stock valued at $52,000 after buying an additional 1,238 shares during the period. Finally, GAMMA Investing LLC raised its holdings in Azenta by 43.8% in the third quarter. GAMMA Investing LLC now owns 4,454 shares of the company’s stock valued at $155,000 after buying an additional 1,357 shares during the period. 99.08% of the stock is currently owned by hedge funds and other institutional investors.
Azenta Company Profile
Azenta, Inc (NASDAQ: AZTA) is a life sciences company that provides products and services for the management, storage, and analysis of biological and chemical samples. Its offerings support pharmaceutical and biotechnology companies, academic and government research institutions, clinical research organizations, and other laboratories.
The company’s products include automated sample storage systems, laboratory automation equipment, sample-management software, consumables, and cold-storage solutions designed to preserve and track biological materials.
Featured Articles
- Five stocks we like better than Azenta
- The Pentagon’s $350 Million Quantum Push: Why IonQ Could Benefit More Than D-Wave
- Delta’s Guidance Cut Could Spell Trouble for the Airline Industry
- Salesforce Just Got a Rare Double Upgrade—What Changed?
- OpenAI’s Revenue Scare Could Be a Big Opportunity for Investors
Receive News & Ratings for Azenta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Azenta and related companies with MarketBeat.com's FREE daily email newsletter.
